- Title: Subtitle
- LB-2Avian Influenza A/H7N9 Vaccine Mixed with MF59 Adjuvant at the Point-of-Use. A Randomized Clinical Trial of a Pandemic Threat Response
- Creators
- Mark J. Mulligan - Emory and Henry CollegeDavid Bernstein - Cincinnati Children's Hospital Medical CenterPatricia Winokur - University of IowaRichard Rupp - The University of Texas Medical Branch at GalvestonLilin Lai - Emory UniversityEvan J. Anderson - Emory UniversityNadine Rouphael - Emory UniversityMichelle Dickey - Cincinnati Children's Hospital Medical CenterJack T. Stapleton - Iowa City VA Medical CenterSrilatha Edupuganti - Emory University School of MedicinePaul W. Spearman - Emory University School of MedicineSarah Kabbani - Emory UniversityDilek Ince - University of IowaDiana L. Noah - Southern Research InstituteHeather Hill - Emmes (United States)Abbie R. Bellamy - Emmes (United States)
- Resource Type
- Abstract
- Publication Details
- Open forum infectious diseases, Vol.1(suppl_1), pp.S66-S67
- DOI
- 10.1093/ofid/ofu083.02
- ISSN
- 2328-8957
- eISSN
- 2328-8957
- Language
- English
- Date published
- 12/01/2014
- Academic Unit
- Microbiology and Immunology; Infectious Diseases; Medicine Administration; Internal Medicine
- Record Identifier
- 9984297513902771
Abstract
LB-2Avian Influenza A/H7N9 Vaccine Mixed with MF59 Adjuvant at the Point-of-Use. A Randomized Clinical Trial of a Pandemic Threat Response
Open forum infectious diseases, Vol.1(suppl_1), pp.S66-S67
12/01/2014
DOI: 10.1093/ofid/ofu083.02
Details
Metrics
8 Record Views